- Home
- AVTX vs TETE Comparison
AVTX vs TETE Comparison
Compare AVTX & TETE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- TETE
- Stock Information
- Founded
- AVTX 2011
- TETE 2021
- Country
- AVTX United States
- TETE Malaysia
- Employees
- AVTX N/A
- TETE N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- TETE Blank Checks
- Sector
- AVTX Health Care
- TETE Finance
- Exchange
- AVTX Nasdaq
- TETE Nasdaq
- Market Cap
- AVTX 90.9M
- TETE 73.0M
- IPO Year
- AVTX 2015
- TETE 2022
- Fundamental
- Price
- AVTX $10.13
- TETE $12.21
- Analyst Decision
- AVTX Buy
- TETE
- Analyst Count
- AVTX 2
- TETE 0
- Target Price
- AVTX $35.00
- TETE N/A
- AVG Volume (30 Days)
- AVTX 59.3K
- TETE 6.4K
- Earning Date
- AVTX 11-07-2024
- TETE 01-01-0001
- Dividend Yield
- AVTX N/A
- TETE N/A
- EPS Growth
- AVTX N/A
- TETE N/A
- EPS
- AVTX N/A
- TETE 0.02
- Revenue
- AVTX $820,000.00
- TETE N/A
- Revenue This Year
- AVTX N/A
- TETE N/A
- Revenue Next Year
- AVTX N/A
- TETE N/A
- P/E Ratio
- AVTX N/A
- TETE $693.17
- Revenue Growth
- AVTX N/A
- TETE N/A
- 52 Week Low
- AVTX $3.95
- TETE $11.07
- 52 Week High
- AVTX $34.46
- TETE $12.25
- Technical
- Relative Strength Index (RSI)
- AVTX 37.71
- TETE 57.47
- Support Level
- AVTX $12.00
- TETE $11.49
- Resistance Level
- AVTX $13.59
- TETE $12.21
- Average True Range (ATR)
- AVTX 0.96
- TETE 0.13
- MACD
- AVTX -0.50
- TETE 0.00
- Stochastic Oscillator
- AVTX 17.42
- TETE 100.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About TETE Technology & Telecommunication Acquisition Corporation
Technology & Telecommunication Acquisition Corp is a blank check company.